Cargando…

Coronary Microvascular Angina: A State-of-the-Art Review

Up to 60–70% of patients, undergoing invasive coronary angiography due to angina and demonstrable myocardial ischemia with provocative tests, do not have any obstructive coronary disease. Coronary microvascular angina due to a dysfunction of the coronary microcirculation is the underlying cause in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spione, Francesco, Arevalos, Victor, Gabani, Rami, Sabaté, Manel, Brugaletta, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005807/ https://www.ncbi.nlm.nih.gov/pubmed/35433857 http://dx.doi.org/10.3389/fcvm.2022.800918

Ejemplares similares

Doppler Echocardiography Assessment of Coronary Microvascular Function in Patients With Angina and No Obstructive Coronary Artery Disease
por: Schroder, Jakob, et al.
Publicado: (2021)

Acute and Chronic Effects of COVID-19 on the Cardiovascular System
por: Arévalos, Victor, et al.
Publicado: (2021)

Incremental value of non-invasive myocardial work for the evaluation and prediction of coronary microvascular dysfunction in angina with no obstructive coronary artery disease
por: Li, Ying, et al.
Publicado: (2023)

The Central Nervous System and Psychosocial Factors in Primary Microvascular Angina
por: Cattaneo, Mattia, et al.
Publicado: (2022)

Research Progress of Imaging Methods for Detection of Microvascular Angina Pectoris in Diabetic Patients
por: Qi, Yiming, et al.
Publicado: (2021)

Editorial: Coronary epicardial and microvascular hemodynamics
por: Polimeni, Alberto, et al.
Publicado: (2022)

Microvascular Myocardial Ischemia in Patients With Diabetes Without Obstructive Coronary Stenosis and Its Association With Angina
por: Yu, Yarong, et al.
Publicado: (2023)

Percutaneous Device to Narrow the Coronary Sinus: Shifting Paradigm in the Treatment of Refractory Angina? A Review of the Literature
por: Benedetto, Daniela, et al.
Publicado: (2016)

Coronary microvascular dysfunction: A review of recent progress and clinical implications
por: Rehan, Rajan, et al.
Publicado: (2023)

Sex Differences in Coronary Function Test Results in Patient With Angina and Nonobstructive Disease
por: Jansen, Tijn P. J., et al.
Publicado: (2021)

Alcohol Septal Ablation: An Option on the Rise in Hypertrophic Obstructive Cardiomyopathy
por: Arévalos, Victor, et al.
Publicado: (2021)

Bibliometric and visual analysis of coronary microvascular dysfunction
por: Lin, Xiaoxiao, et al.
Publicado: (2022)

Sex differences in contributors to coronary microvascular dysfunction
por: Kwan, Alan C., et al.
Publicado: (2023)

Coronary microvascular dysfunction in heart failure patients
por: Toya, Takumi, et al.
Publicado: (2023)

Does anxiety cause angina recurrence after percutaneous coronary intervention in patients with STEMI?
por: Zhang, Zhipeng, et al.
Publicado: (2023)

Reduced Microvascular Blood Volume as a Driver of Coronary Microvascular Disease in Patients With Non-obstructive Coronary Artery Disease: Rationale and Design of the MICORDIS Study
por: Vink, Caitlin E. M., et al.
Publicado: (2021)

Diabetes mellitus: a prothrombotic state Implications for outcomes after coronary revascularization
por: Cola, Clarissa, et al.
Publicado: (2009)

Assessment and Treatment for Coronary Microvascular Dysfunction by Contrast Enhanced Ultrasound
por: Zhan, Junzhen, et al.
Publicado: (2022)

Outpatient Management of Patients With Angina With No Obstructive Coronary Arteries: How to Come to a Proper Diagnosis and Therapy
por: Meeder, Joan G., et al.
Publicado: (2021)

Drug repurposing—a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA)
por: McChord, Johanna, et al.
Publicado: (2023)

Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve
por: Gallinoro, Emanuele, et al.
Publicado: (2021)

Coronary Microvascular Dysfunction in Patients With Systemic Lupus Erythematosus and Chest Pain
por: Manchanda, Ashley S., et al.
Publicado: (2022)

Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men
por: WANNAMETHEE, S G, et al.
Publicado: (2009)

Effects of Oral Drugs on Coronary Microvascular Function in Patients Without Significant Stenosis of Epicardial Coronary Arteries: A Systematic Review and Meta-Analysis of Coronary Flow Reserve
por: Yong, Jingwen, et al.
Publicado: (2020)

Coronary microvascular dysfunction as assessed by angiography-derived index of microvascular resistance co-localizes with and may explain the presence of ischemia in stress-cardiac magnetic resonance imaging in the absence of coronary artery disease
por: Milzi, Andrea, et al.
Publicado: (2022)

Mid-term effects of SARS-CoV-2 infection on cardiovascular outcomes
por: Arévalos, Victor, et al.
Publicado: (2022)

Mid-term effects of SARS-CoV-2 infection on cardiovascular outcomes
por: Arévalos, Victor, et al.
Publicado: (2022)

Radiation-Induced Vascular Disease—A State-of-the-Art Review
por: Yang, Eric H., et al.
Publicado: (2021)

The Role of Artificial Intelligence in Cardiovascular Imaging: State of the Art Review
por: Seetharam, Karthik, et al.
Publicado: (2020)

D-Dimer Is Associated With Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease and Preserved Ejection Fraction
por: Lin, Yan, et al.
Publicado: (2022)

Quality of the Evidence Supporting the Role of Acupuncture for Stable Angina Pectoris: An Umbrella Review of Systematic Reviews
por: Shen, Min, et al.
Publicado: (2021)

A Landscape of Metabonomics for Intermingled Phlegm and Blood Stasis and Its Concurrent Syndromes in Stable Angina Pectoris of Coronary Heart Disease
por: Zheng, Li, et al.
Publicado: (2022)

Alprostadil vs. isosorbide dinitrate in ameliorating angina episodes in patients with coronary slow flow phenomenon: A randomized controlled trial
por: Zhang, Weifeng, et al.
Publicado: (2022)

Sex differences in coronary microvascular resistance measured by a computational fluid dynamics model
por: Taylor, Daniel J., et al.
Publicado: (2023)

Persistent chest pain after recovery of COVID-19: microvascular disease-related angina?
por: Vallejo, Nuria, et al.
Publicado: (2021)

Bioresorbable vascular scaffold implantation in acute coronary syndromes: clinical evidence, tips and tricks
por: Giacchi, Giuseppe, et al.
Publicado: (2015)

Automatic Estimation of Coronary Blood Flow Velocity Step 1 for Developing a Tool to Diagnose Patients With Micro-Vascular Angina Pectoris
por: Khanmohammadi, Mahdieh, et al.
Publicado: (2019)

Integrated Chinese and Western medicine for stable angina pectoris of coronary heart disease: a real-world study including 690 patients
por: Yu, Linghua, et al.
Publicado: (2023)

Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mice
por: Tu, Yimin, et al.
Publicado: (2022)

The impact of coronary microvascular dysfunction on the discordance between fractional flow reserve and resting full-cycle ratio in patients with chronic coronary syndromes
por: Legutko, Jacek, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eruef72ta4sumg29a4gbs11so0